Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Next-Generation Diagnostics - SciLifeLab symposium

21 September 2016 08:00-19:00, Stockholm, Sweden


Introduction
The SciLifeLab Clinical Diagnostics platform arranges an exciting one day symposium covering novel strategies for introduction of next-generation diagnostics in the diagnostic setup of e.g. cancer, cardiovascular diseases, and inherited conditions. We are glad to be able to announce a high-quality program with a distinguished faculty including prominent speakers from Germany, Finland, the Netherlands, Sweden, the UK, and the USA.
Speakers
  • Olli Kallioniemi SciLifeLab, Stockholm , Sweden
  • Richard Rosenquist Uppsala University, Sweden
  • Clare Turnbull Queen Mary University of London, United Kingdom
  • Agneta Siegbahn Uppsala University, Sweden
  • Jan Nilsson Lund University , Sweden
  • Marcel Nelen Radboud University, Nijmegen , Netherlands
  • Valtteri Wirta SciLifeLab, Stockholm , Sweden
  • Anna Wedell Karolinska Institutet, Sweden
  • Heidi Howard Uppsala University, Sweden
  • Serena Nik-Zainal Wellcome Trust Sanger Institute, United Kingdom
  • Mark Ladanyi Memorial Sloan-Kettering Cancer Center, United States
  • Torsten Haferlach MLL Laboratory, Munich, Germany
  • Caroline Heckman FiMM, Helsinki , Finland
  • Ulf Gyllensten Uppsala University, Sweden
  • Ulf Landegren Uppsala University, Sweden

Venue
Karolinska Institutet

Aula Medica, Karolinska Institutet, Nobels väg 6, Stockholm, 171 65, Sweden

Organised by
The Next-Generation Diagnostics (NGD) facility has been established at SciLifeLab Stockholm and Uppsala to facilitate the translation of new high-throughput (HTP) techniques, such as next-generation sequencing (NGS), microarray-based analyses and multiplex protein analysis, in biological samples into clinical use. The overall aim for the platform is to meet clinical diagnostic needs in the health-care and public health systems by providing service and support at the national level in order to promote and adapt the use of HTP techniques in routine diagnostics.
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*